US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 10.400
  • -0.210-1.98%
Close Jun 12 16:00 ET
  • 10.266
  • -0.134-1.29%
Post 20:01 ET
2.18BMarket Cap-40.00P/E (TTM)

BioCryst Pharmaceuticals Key Stats

BioCryst Pharmaceuticals Q1 2025 Earnings Date

Currency:USDMay 5, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
127.79M
145.53M
+17.75M
Beat Est.
+37.76%
+56.89%
+13.89%
Net Income
--
32.00K
--
+100.09%
Strong Buy

May 31, 2025

BioCryst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 156.512M--
--2025/Q2-- / 149.529M--
May 5, 20252025/Q1145.534M / 127.787M--
Feb 24, 20252024/Q4131.534M / 130.047M--
Nov 4, 20242024/Q3117.085M / 112.666M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 156.512M--
--2025/Q2-- / 149.529M--
May 5, 20252025/Q1145.534M / 127.787M--
Feb 24, 20252024/Q4131.534M / 130.047M--
Nov 4, 20242024/Q3117.085M / 112.666M--

Unlock Free Earnings Estimates

BioCryst Pharmaceuticals Earnings Reports

Read more

Market Insights

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.